A 6-Day Losing Streak Has Rocket Lab Stock Down 23%
Today’s big story: Will 2027 Be A 2022 Repeat For Stocks?
Rocket Lab (RKLB) stock is on a 6-day losing streak, down 22.9% since the run began. That erased about $9.9 billion from the company’s market value, which now stands at about $33.3 billion. The stock closed at $50.99 on Thursday, November 19, 66.1% below its 52-week high of $150.23 and 29.2% above its low of $39.48.

How The Streak Stacks Up Against The S&P 500
Returns for RKLB and the S&P 500 over the streak and the periods around it, all ending Thursday, November 19 and including dividends:
| Return Period | RKLB | S&P 500 |
|---|---|---|
| 1 Day | -3.9% | -2.0% |
| 6 Days (Current Streak) | -22.9% | -5.8% |
| 1 Month (21 Trading Days) | -5.0% | -7.4% |
| 3 Months (63 Trading Days) | -29.7% | -6.2% |
| Year To Date | -26.9% | 5.9% |
| 1 Year (252 Trading Days) | 19.2% | 9.7% |
How The Streak Compares With The Market
Over the same 6 trading days, the S&P 500 returned -5.8% including dividends, so the slide is mostly Rocket Lab’s own story rather than the market’s. Over the past three months the stock is down 29.7%, a window that includes the streak; over the other 57 sessions of that window it was down 8.8%.
What The Numbers Say About The Slide
On the fundamentals, revenue grew 59.0% over the last twelve months, against a median of 8.5% for S&P 500 Industrials stocks; and its operating margin is -27.6%, versus a median of 17.5%. Rocket Lab does not have positive trailing earnings, so there is no meaningful price-to-earnings multiple to compare. The fundamentals give the sellers some support: an operating loss.
If the drop has you weighing an entry, resist buying on price alone. Our Buy the Dip screen ranks the marked-down names where growth and cash generation still hold up.
For anyone who would rather back the theme than one company, an aerospace & defense ETF like MISL holds the whole group, not just this stock. It is still a concentrated bet on one theme, which is the gap the portfolio below is built to close.
Falling Prices Test Conviction. Rules Do Not Flinch
A losing streak forces a choice on every holder: sell into weakness, average down, or freeze. All three are emotional answers to what should be an analytical question, and decisions made that way tend to be expensive ones.
The Trefis High Quality (HQ) Portfolio takes the emotion out: about 30 quality businesses screened for the fundamentals that survive bad stretches, held and rebalanced by rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Let the rules decide, not the tape.